Return On Equity of Raphael Pharmaceutical Inc. from 31 Dec 2021 to 31 Mar 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Raphael Pharmaceutical Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2021 to 31 Mar 2023.
  • Raphael Pharmaceutical Inc. Return On Equity for the quarter ending 31 Mar 2023 was -8986%, a 329% decline year-over-year.
  • Raphael Pharmaceutical Inc. annual Return On Equity for 2022 was -5069%, a 181% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Raphael Pharmaceutical Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2023 -8986% -6891% -329% 01 Jan 2023 31 Mar 2023
Q4 2022 -5069% -11319% -181% 01 Oct 2022 31 Dec 2022
Q3 2022 -3933% 01 Jul 2022 30 Sep 2022
Q2 2022 -3205% 01 Apr 2022 30 Jun 2022
Q1 2022 -2094% 01 Jan 2022 31 Mar 2022
Q4 2021 6250% 01 Oct 2021 31 Dec 2021

Raphael Pharmaceutical Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 -5069% -11319% -181% 01 Jan 2022 31 Dec 2022
2021 6250% 01 Jan 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.